BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4942741)

  • 1. Controlled clinical trial of clofazimine in untreated lepromatous leprosy.
    Karat AB; Jeevaratnam A; Karat S; Rao PS
    Br Med J; 1971 Nov; 4(5786):514-6. PubMed ID: 4942741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy.
    Karat AB; Jeevaratnam A; Karat S; Rao PS
    Br Med J; 1970 Jan; 1(5690):198-200. PubMed ID: 4904935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy.
    Karat AB; Jeevaratnam A; Karat S; Rao PS
    Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of moderately severe erythema nodosum leprosum with clofazimine--a controlled trial.
    Helmy HS; Pearson JM; Waters MF
    Lepr Rev; 1971 Sep; 42(3):167-77. PubMed ID: 4339652
    [No Abstract]   [Full Text] [Related]  

  • 5. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)).
    Schulz EJ
    Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibacterial effects of G 30'320 Geigy (B663) in lepromatous leprosy.
    Hastings RC; Trautman JR; Mansfield RE
    Dermatol Int; 1969; 8(1):21-7. PubMed ID: 5343403
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
    [No Abstract]   [Full Text] [Related]  

  • 8. A Traditional NSAID Aspirin along with Clofazimine in Erythema Nodosum Leprosum Reaction: Study of Six Cases.
    Sharma PK; Singh DK
    Indian J Lepr; 2016 Sep; 87(4):249-253. PubMed ID: 29762954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'B 663' POSSIBLE ANTI-INFLAMMATORY ACTION IN LEPROMATOUS LEPROSY.
    BROWNE SG
    Lepr Rev; 1965 Jan; 36():9-11. PubMed ID: 14241920
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
    Waters MF; Rees RJ; Sutherland I
    Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
    [No Abstract]   [Full Text] [Related]  

  • 11. Thymus-dependent lymphocytes of peripheral blood in leprosy patients.
    Lim SD; Kiszkiss DF; Jacobson RR; Choi YS; Good RA
    Infect Immun; 1974 Feb; 9(2):394-9. PubMed ID: 4544619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 13. Clofazimine and dapsone--a combination therapy in erythema nodosum leprosum syndrome.
    Dutta RK
    Lepr India; 1980 Apr; 52(2):252-9. PubMed ID: 7453140
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of erythema nodosum leprosum with B.663. A controlled study.
    Pettit JH
    Int J Lepr Other Mycobact Dis; 1967; 35(1):11-6. PubMed ID: 4290017
    [No Abstract]   [Full Text] [Related]  

  • 15. Possible incompatibility of dapsone with clofazimine in the treatment of patients with erythema nodosum leprosum.
    Imkamp FM; Anderson R; Gatner EM
    Lepr Rev; 1982 Jun; 53(2):148-9. PubMed ID: 7098753
    [No Abstract]   [Full Text] [Related]  

  • 16. [Histoid leprosy with erythema nodosum leprosum].
    Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
    Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of dapsone (DDS) therapy to erythema nodosum leprosum. Is it direct or indirect?
    Waters MF; Helmy HS
    Lepr Rev; 1974 Dec; 45(4):299-307. PubMed ID: 4613978
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral zinc in recurrent Erythema Nodosum Leprosum reaction.
    Mathur NK; Bumb RA; Mangal HN
    Lepr India; 1983 Jul; 55(3):547-52. PubMed ID: 6656212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.